Kevin Coleman

6.6k total citations · 5 hit papers
41 papers, 4.8k citations indexed

About

Kevin Coleman is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Kevin Coleman has authored 41 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 13 papers in Oncology and 8 papers in Hematology. Recurrent topics in Kevin Coleman's work include Protein Degradation and Inhibitors (12 papers), Multiple Myeloma Research and Treatments (8 papers) and Ubiquitin and proteasome pathways (6 papers). Kevin Coleman is often cited by papers focused on Protein Degradation and Inhibitors (12 papers), Multiple Myeloma Research and Treatments (8 papers) and Ubiquitin and proteasome pathways (6 papers). Kevin Coleman collaborates with scholars based in United States, Germany and Denmark. Kevin Coleman's co-authors include Craig M. Crews, Stephen J. Poole, Thomas B. Kornberg, Andrew P. Crew, Kanak Raina, Yimin Qian, James D. Winkler, Jing Wang, Hanqing Dong and Nipam H. Patel and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Kevin Coleman

40 papers receiving 4.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Expression of engrailed proteins in arthropods, annelids, and chordates

1989 903 citations Nipam H. Patel, Enrique Martı́n-Blanco et al. Cell profile →
Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4

2015 849 citations Jing Lü, Yimin Qian et al. Chemistry & Biology profile →
Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2

2003 693 citations Xiao-ding Peng, Mei-Ling Chen et al. Genes & Development profile →
PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer

2016 661 citations Kanak Raina, Jing Lü et al. Proceedings of the National Academy of Sciences profile →
Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKBβ

2003 594 citations Robert S. Garofalo, Stephen Orena et al. Journal of Clinical Investigation profile →

Peers

Kevin Coleman

ONCOL

HEMAT

GENET

CMN

Lisa Garrett United States

Robert Latek United States

Dalia Baršytė-Lovejoy Canada

Brian Duckworth United States

Javier León Spain

Serge Roche France

Marco Crescenzi Italy

Hung‐Ying Kao United States

Rosa Bernardi Italy

Lisa Garrett United States

Kevin Coleman

3.1k ×0.8

1.3k ×1.4

ONCOL

346 ×0.5

HEMAT

874 ×1.8

GENET

397 ×1.0

CMN

Citations per year, relative to Kevin Coleman Kevin Coleman (= 1×) peers Lisa Garrett

Countries citing papers authored by Kevin Coleman

Since Specialization

Citations

This map shows the geographic impact of Kevin Coleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Coleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Coleman more than expected).

Fields of papers citing papers by Kevin Coleman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Coleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Coleman. The network helps show where Kevin Coleman may publish in the future.

Co-authorship network of co-authors of Kevin Coleman

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Coleman. A scholar is included among the top collaborators of Kevin Coleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Coleman. Kevin Coleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Coleman, Kevin, et al.. (2024). PARP inhibitor synthetic lethality in ATM biallelic mutant cancer cell lines is associated with BRCA1/2 and RAD51 downregulation. Frontiers in Oncology. 14. 1380633–1380633. 4 indexed citations

Mirza, Mansoor Raza, Bin Feng, Ming Shan, et al.. (2019). Elucidation of PARP inhibitor activity in BRCAwt recurrent ovarian cancer by hrr mutational gene profile analysis.. Journal of Clinical Oncology. 37(15_suppl). 5568–5568. 2 indexed citations

Sun, Baohua, Warren Fiskus, Yimin Qian, et al.. (2017). BET protein proteolysis targeting chimera (PROTAC) exerts potent lethal activity against mantle cell lymphoma cells. Leukemia. 32(2). 343–352. 136 indexed citations

Coleman, Kevin & Craig M. Crews. (2017). Proteolysis-Targeting Chimeras: Harnessing the Ubiquitin-Proteasome System to Induce Degradation of Specific Target Proteins. 2(1). 41–58. 52 indexed citations

Winkler, Julia, Kanak Raina, Martha Altieri, et al.. (2016). PROTAC BET degraders are more broadly effective than BET inhibitors. European Journal of Cancer. 69. S10–S10. 3 indexed citations

Raina, Kanak, Jing Lü, Yimin Qian, et al.. (2016). PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer. Proceedings of the National Academy of Sciences. 113(26). 7124–7129. 661 indexed citations breakdown →

Lü, Jing, Yimin Qian, Martha Altieri, et al.. (2015). Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4. Chemistry & Biology. 22(6). 755–763. 849 indexed citations breakdown →

Jani, Jitesh P., Richard S. Finn, Mary E. Campbell, et al.. (2007). Discovery and Pharmacologic Characterization of CP-724,714, a Selective ErbB2 Tyrosine Kinase Inhibitor. Cancer Research. 67(20). 9887–9893. 62 indexed citations

Du, Ping, Chun Luo, Anil Mistry, et al.. (2005). Phosphorylation of serine residues in histidine-tag sequences attached to recombinant protein kinases: A cause of heterogeneity in mass and complications in function. Protein Expression and Purification. 44(2). 121–129. 20 indexed citations

10.

Garofalo, Robert S., Stephen Orena, Kristina Rafidi, et al.. (2003). Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKBβ. Journal of Clinical Investigation. 112(2). 197–208. 594 indexed citations breakdown →

11.

Peng, Xiao-ding, Mei-Ling Chen, Annett Hahn-Windgassen, et al.. (2003). Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes & Development. 17(11). 1352–1365. 693 indexed citations breakdown →

12.

Awwad, Rana, Lisa E. Humphrey, William M. Scovell, et al.. (1999). The EGF/TGFα response element within the TGFα promoter consists of a multi-complex regulatory element. Oncogene. 18(43). 5923–5935. 7 indexed citations

13.

Howell, Gillian, Lisa E. Humphrey, Barry L. Ziober, et al.. (1998). Regulation of Transforming Growth Factor α Expression in a Growth Factor-Independent Cell Line. Molecular and Cellular Biology. 18(1). 303–313. 16 indexed citations

14.

Howell, Gillian, Lisa E. Humphrey, Rana Awwad, et al.. (1998). Aberrant Regulation of Transforming Growth Factor-α during the Establishment of Growth Arrest and Quiescence of Growth Factor Independent Cells. Journal of Biological Chemistry. 273(15). 9214–9223. 17 indexed citations

15.

Coleman, Kevin, Barri Wautlet, Dylan Morrissey, et al.. (1997). Identification of CDK4 Sequences Involved in Cyclin D1 and p16 Binding. Journal of Biological Chemistry. 272(30). 18869–18874. 79 indexed citations

16.

Sun, Lu‐Zhe, et al.. (1994). Autocrine Transforming Growth Factor-β1 and β2 Expression Is Increased by Cell Crowding and Quiescence in Colon Carcinoma Cells. Experimental Cell Research. 214(1). 215–224. 25 indexed citations

17.

Gorney, D. J. & Kevin Coleman. (1991). Expert systems development standards. Expert Systems with Applications. 2(4). 239–243. 1 indexed citations

18.

Patel, Nipam H., Enrique Martı́n-Blanco, Kevin Coleman, et al.. (1989). Expression of engrailed proteins in arthropods, annelids, and chordates. Cell. 58(5). 955–968. 903 indexed citations breakdown →

19.

Coleman, Kevin, Stephen J. Poole, Michael P. Weir, Walter C. Soeller, & Thomas B. Kornberg. (1987). The invected gene of Drosophila: sequence analysis and expression studies reveal a close kinship to the engrailed gene.. Genes & Development. 1(1). 19–28. 142 indexed citations

20.

Coleman, Kevin, H. Yde Steensma, David B. Kaback, & John R. Pringle. (1986). Molecular Cloning of Chromosome I DNA from Saccharomyces cerevisiae: Isolation and Characterization of the CDC24 Gene and Adjacent Regions of the Chromosome. Molecular and Cellular Biology. 6(12). 4516–4525. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact